27 September 2018
Organised by:
SCI's Young Chemists' Panel
London, UK
This event is no longer available for registration.
09.15 | Registration and refreshments | |
09.55 | Opening remarks | |
10.05 | An introduction to in vivo pharmacology in drug discovery Alex Vugler, UCB UK |
|
10.55 | What makes a good target? Identification and validation of targets for drug discovery Peter Joyce, Grey Wolf Therapeutics |
|
11.45 | Refreshment break | |
12.10 | Preclinical and clinical utilisation of biomarkers in oncology drug discovery Chris Morrow, AstraZeneca |
|
13.00 | Lunch and exhibition | |
14.00 | Synaptic Vesicle Protein 2A (SV2A): from phenotypic screen and target identification to drug approval and biomarker development Joel Mercier, UCB Belgium |
|
14.55 | Following the pharmacological audit trail: from binding to efficacy with CHK1 inhibitors Ian Collins, Institute of Cancer Research |
|
15.50 | Refreshment break | |
16.20 | Application of in vivo PKPD to determine target engagement and mechanism of action for anti-inflammatory projects Simon Peace, GlaxoSmithKline |
|
17.15 | Final Q&A and closing statements | |
17.30 | Networking and refreshments |
SCI
14/15 Belgrave Square
London
SW1X 8PS
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org
Early bird fees before Tuesday 4 September 2018
£125 | SCI Member | |
£40 | SCI Student Member | |
£65 | SCI Subsidised Member | |
£17 | Non-Member |
Standard fees after Tuesday 4 September 2018
£175 | SCI Member | |
£55 | SCI Student Member | |
£90 | SCI Subsidised Member | |
£240 | Non-Member |
SCI Platinum Corporate Members receive 25% off the above rates.
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.